Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents

AIDS Research and Human Retroviruses

Volumn 20, Issue 3, 2004, Pages 305-313

  Tuttle, Daniel L ^a   Coberley, Carter R ^a   Xie, Xiaoming ^a   Kou, Zhong C ^a   Sleasman, John W ^a,b   Goodenow, Maureen M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; PHYTOHEMAGGLUTININ;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGING; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; RECEPTORS, CCR5; RECEPTORS, CXCR4; T-LYMPHOCYTE SUBSETS;

EID: 1842607079     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922204322996545     Document Type: Article

References (48)

1. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, and Hendrickson WA: Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393:648-659.
2. Clapham PR and McKnight A: Cell surface receptors, virus entry and tropism of primate lentiviruses. J Gen Virol 2002;83:1809-1829.
3. Blaak H, Ran LJ, Rientsma R, and Schuitemaker H: Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production. Virology 2000;267:237-246.
4. Cayabyab M, Karlsson GB, Etemad-Moghadam BA, Hofmann W, Steenbeke T, Halloran M, Fanton JW, Axthelm MK, Letvin NL, and Sodroski JG: Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2). J Virol 1999;73:976-984.
5. van Rij RP, Blaak H, Visser JA, Brouwer M, Rientsma R, Broersen S, Roda Husman AM, and Schuitemaker H: Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. J Clin Invest 2000;106:1569.
6. Wallace DL and Beverley PC: Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells. Immunology 1990;69:460-467.
7. Beverley PC: Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin Immunol 1992;4:35-41.
8. Johannisson A and Festin R: Phenotype transition of CD4+ T cells from CD45RA to CD45R0 is accompanied by cell activation and proliferation. Cytometry 1995;19:343-352.
9. Arlettaz L, Barbey C, Dumont-Girard F, Helg C, Chapuis B, Roux E, and Roosnek E: CD45 isoform phenotypes of human T cells: CD4(+)CD45RA(-)RO(+) memory T cells re-acquire CD45RA without losing CD45RO. Eur J Immunol 1999;29:3987-3994.
10. Hamann D, Baars PA, Hooibrink B, and van Lier RW: Heterogeneity of the human CD4+ T-cell population: Two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood 1996;88:3513-3521.
11. Kitchen SG and Zack JA: Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 in fetal lymphoid organs: implications for pathogenesis in utero. AIDS Res Hum Retroviruses 1999;15:143-148.
12. Bleul CC, Wu L, Hoxie JA, Springer TA, and Mackay CR: The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997;94:1925-1930.
13. Mo H, Monard S, Pollack H, Ip J, Rochford G, Wu L, Hoxie J, Borkowsky W, Ho DD, and Moore JP: Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood. AIDS Res Hum Retroviruses 1998;14:607-617.
14. Ostrowski MA, Justement SJ, Catanzaro A, Hallahan CA, Ehler LA, Mizell SB, Kumar PN, Mican JA, Chun TW, and Fauci AS: Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 1998;161:3195-3201.
15. Schnittman SM, Lane HC, Greenhouse J, Justement JS, Baseler M, and Fauci AS: Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 1990;87:6058-6062.
16. Blaak H, van't Wout AB, Brouwer M, Hooibrink B, Hovenkamp E, and Schuitemaker H: In vivo HIV-1 infection of CD45RA(+) CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. Proc Natl Acad Sci USA 2000;97:1269-1274.
17. De Paoli P, Battistin S, and Santini GF: Age-related changes in human lymphocyte subsets: Progressive reduction of the CD4 CD45R (suppressor inducer) population. Clin Immunol Immunopathol 1988;48:290-296.
18. Plaeger-Marshall S, Hultin P, Bertolli J, O'Rourke S, Kobayashi R, Kobayashi AL, Giorgi JV, Bryson Y, and Stiehm ER: Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children. J Acquir Immune Defic Syndr 1993;6:984-993.
19. Ometto L, Bertorelle R, Mainardi M, Zanchetta M, Tognazzo S, Rampon O, Ruga E, Chieco-Bianchi L, and De Rossi A: Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children. J Infect Dis 2001;183:814-818.
20. Cohen OJ, Paolucci S, Bende SM, Daucher M, Moriuchi H, Moriuchi M, Cicala C, Davey RT Jr, Baird B, and Fauci AS: CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: Lack of association with mutations other than CCR5-Delta32. J Virol 1998;72:6215-6217.
21. Centers for Disease Control and Prevention: 1994 revised classification system for HIV infection in children less than 13 years of age. MMWR 1994;43:1-19.
22. Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL, and Curran JW: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19.
23. Tuttle DL, Harrison JK, Anders C, Sleasman JW, and Goodenow MM: Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol 1998;72:4962-4969.
24. Sleasman JW, Leon BH, Aleixo LF, Rojas M, and Goodenow MM: Immunomagnetic selection of purified monocyte and lymphocyte populations from peripheral blood mononuclear cells following cryopreservation. Clin Diagn Lab Immunol 1997;4:653-658.
25. Peden K, Emerman M, and Montagnier L: Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology 1991;185:661-672.
26. Zolotukhin S, Potter M, Hauswirth WW, Guy J, and Muzyczka N: A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996;70:4646-4654.
27. Graham FL, Smiley J, Russell WC, and Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977;36:59-74.
28. AIDS Clinical Trial Group: Virology Manual for HIV Laboratories, 1997.
29. Bryson YJ, Luzuriaga K, Sullivan JL, and Wara DW: Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 1992;327:1246-1247.
30. Rich KC, Fowler MG, Mofenson LM, Abboud R, Pitt J, Diaz C, Hanson IC, Cooper E, and Mendez H: Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group. Pediatrics 2000;105:e8.
31. Holland CA, Ellenberg JH, Wilson CM, Douglas SD, Futterman DC, Kingsley LA, and Moscicki AB: Relationship of CD4+ T cell counts and HIV type 1 viral loads in untreated, infected adolescents. Adolescent Medicine HIV/AIDS Research Network. AIDS Res Hum Retroviruses 2000;16:959-963.
32. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, and Kabat D: Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 1998;72:2855-2864.
33. Amlot PL, Tahami F, Chinn D, and Rawlings E: Activation antigen expression on human T cells. I. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue. Clin Exp Immunol 1996;105:176-182.
34. Serra HM, Krowka JF, Ledbetter JA, and Pilarski LM: Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event. J Immunol 1988;140:1435-1441.
35. Kourtis AP, Ibegbu C, Nahmias AJ, Lee FK, Clark WS, Sawyer MK, and Nesheim S: Early progression of disease in HIV-infected infants with thymus dysfunction. N Engl J Med 1996;335:1431-1436.
36. Plaeger-Marshall S, Isacescu V, O'Rourke S, Bertolli J, Bryson YJ, and Stiehm ER: T cell activation in pediatric AIDS pathogenesis: Three-color immunophenotyping. Clin Immunol Immunopathol 1994;71:19-26.
37. Lim LC, Fiordalisi MN, Mantell JL, Schmitz JL, and Folds JD: A whole-blood assay for qualitative and semiquantitative measurements of CD69 surface expression on CD4 and CD8 T lymphocytes using flow cytometry. Clin Diagn Lab Immunol 1998;5:392-398.
38. Bohler T, Walcher J, Holzl-Wenig G, Schnitzler P, Geiss M, Buchholz B, Linde R, Rutschle H, and Debatin KM: Expression of CD69 on T-cells from HIV-1-infected children and adolescents increases with increasing viral load. Eur J Pediatr 1999;158:638-644.
39. Pedroza-Martins L, Gumey KB, Torbett BE, and Uittenbogaart CH: Differential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: Coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level. J Virol 1998;72:9441-9452.
40. Peakman M, Mahalingam M, Pozniak A, McManus TJ, Phillips AN, and Vergani D: Markers of immune cell activation and disease progression. Cell activation in HIV disease. Adv Exp Med Biol 1995;374:17-26.
41. Sleasman JW, Aleixo LF, Morton A, Skoda-Smith S, and Goodenow MM: CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children. AIDS 1996;10:1477-1484.
42. LeMaoult J, Szabo P, and Weksler ME: Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol Rev 1997;160:115-126.
43. Luzuriaga K, McManus M, Catalina M, Mayack S, Sharkey M, Stevenson M, and Sullivan JL: Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: Control of viral replication and absence of persistent HIV-1-specific immune responses. J Virol 2000;74:6984-6991.
44. Luzuriaga K and Sullivan JL: Viral and immunopathogenesis of vertical HIV-1 infection. Pediatr Clin North Am 2000;47:65-78.
45. Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, Rich K, Handelsman E, Diaz C, Pagano M, Smeriglio V, and Kalish LA: Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 1997;336:1337-1342.
46. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, and Koup RA: Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-695.
47. Smith RA, Ellenberg JH, Douglas SD, Henry-Reid L, Peralta L, and Wilson CM: The prevalence of anergy in human immunodeficiency virus-infected adolescents and the association of delayed-type hypersensitivity with subject characteristics. J Adolesc Health 2000;27:384-390.
48. Rudy BJ, Wilson CM, Durako S, Moscicki AB, Muenz L, and Douglas SD: Peripheral blood lymphocyte subsets in adolescents: A longitudinal analysis from the REACH project. Clin Diagn Lab Immunol 2002;9:959-965.